Copyright
©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 106197
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106197
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106197
Figure 4 Knockdown of NOTCH1 decreases NT5E to inhibit breast cancer proliferation and migration both in vitro and in vivo.
A: Western blot results validating the efficiency of stable NOTCH1 knockdown combined with stable NT5E overexpression in MDA-MB-231 cells; B and C: CCK-8 and colony formation assay showing that overexpression of NT5E reversed the inhibitory effect of NOTCH1 knockdown on breast cancer cell proliferation and colony formation; D and E: Transwell and scratch assays demonstrating that NT5E overexpression can reverse the inhibitory effect of NOTCH1 knockdown on breast cancer cell invasion and wound healing; F-H: Mouse xenograft tumor model showing that NT5E overexpression reversed the inhibitory effect of NOTCH1 knockdown on triple-negative breast cancer tumorigenesis in vivo. aP < 0.05; bP < 0.01; cP < 0.001.
- Citation: Chen WJ, Wu HT, Lan YZ, Wu Z, Yu XN, Lin WT, Liu J. NOTCH1 combined with chemotherapy synergistically inhibits triple-negative breast cancer. World J Clin Oncol 2025; 16(6): 106197
- URL: https://www.wjgnet.com/2218-4333/full/v16/i6/106197.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i6.106197